You are leaving GSKSource to visit a separate website not associated with GSKSource, a portal for US Healthcare Professionals.There are website links to third-party sites on GSK Source.GSK is not responsible for content on third-party websites.
You must be registered with GSKSource in order to attend an Event/Webinar
Required fieldMedical Science Liaison, MSL
Bhumi is a Vaccines Medical Science Liaison for GlaxoSmithKline serving Missouri and Kansas. She received her Pharm.D from the University of Illinois and previously served as a Clinical Pharmacist in a community hospital primarily focused on infectious disease for 10 years. Prior to that she worked at Pfizer as a MSL.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
IMPLEMENTING SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on implementing SHINGRIX into your practice, and will review clinical data, patient and provider resources, and strategies to counsel patients about SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
An Educational Overview of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted): Now Approved
GSK cordially invites you to learn about SHINGRIX. The presentation will focus on disease information, current treatment and prevention, as well as the pivotal clinical trials and Prescribing Information for SHINGRIX.
Trademarks are property of their respective owners.
827007R0 October 2017
SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older.
SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox).